Drug intelligence / Profile preview

Delsam Pharma Artificial Tears

Development stage
Discontinued
Lead developer
Global Pharma Healthcare
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Delsam Pharma Artificial Tears is an over-the-counter (OTC) ophthalmic lubricant solution containing 1% carboxymethylcellulose sodium. Manufactured by Global Pharma Healthcare and distributed by Delsam Pharma, it is designed to provide temporary relief from dry eye symptoms, including burning and irritation caused by environmental factors like wind or sun. The active ingredient, carboxymethylcellulose sodium, is a high-molecular-weight polymer that increases tear viscosity and stabilizes the tear film, acting as a protectant for the ocular surface. In early 2023, the product was subject to a major voluntary recall following reports of serious bacterial contamination (carbapenem-resistant Pseudomonas aeruginosa) linked to vision loss and other adverse health outcomes.

Brand names
Delsam Pharma Artificial Tears

Beyond the preview

Go deeper on Delsam Pharma Artificial Tears.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delsam Pharma Artificial Tears.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call